Exec Dir & Porf U Washington; Medical & Pharm Sci; Serial Entrepreneur, Educator. Expt on Inf Diseases, Cancer & AIDS Long-acting drug dev. Exec Dir WE-REACH
Announcement of my colleague and @WEREACH1 leadership member David Baker of @UW is one of the 3 recipient of the 2024 Nobel Prize in Chemistry https://t.co/PqMSOo2h0p via @YouTube. #Congratulations.
The TLC-ART program is seeking healthy volunteers for phase 1 studies for TLC-ART 101, a low dose, long-acting combination of 3 current HIV drugs (tenofovir, ritonavir, and lopinavir). Please contact UW Positive Research at 306-773-7129 to volunteer!
#hiv#therapeutics#aids
Excited to share TLC-ART in discovery of targeted and #HIV drug combination technology to clinical stage #LA-DcNP #HARRT product for #PLWH thanks to #NIH#Unitaid#MPP. #ICTMM 2020
Exciting New! Congratulation to @ImpelPharma Team. Very Proud. Helping people with #Neurological#diseases and #symptoms. Impel Pharmaceuticals Rings The Closing Bell | NASDAQ https://t.co/Rt7YrEHH79
Please help with finding people who are passionate about making Global impact on eliminating HIV through Long-acting and targeted, drug combination treatment. Our team is looking for talented scientist in both formulation know-how and bioanalytical exper…https://t.co/NIFHir2TGb
We are excited to share this opportunity at UW Pharmaceutics. The newly created Tenure Track Assistant Position is intended to recruit and mentor an outstanding NextGen Scientist with passion to teach students at UW. Areas of focus includes of drug deliv…https://t.co/n5lfjdaNG5
Students, Post-doc, Scientists, PI, Sponsors, Supporters and Community Advocates are encourage to attend on site or remotely Tuesday March 8. All are welcome. WE-REACH supported PIs, Student and team members will share about their experience working with…https://t.co/SToKJnbAaU
All are welcome. WE-REACH supported PIs, Student and team members will share about their experience working with WE-REACH in successfully moving ideas into innovative products to make health impact. Students, Post-doc, Scientists, PI, Sponsors, Supporter…https://t.co/4S6x7rBsAm
You are invited to join WE-REACH show case in-person at Forge Building University of Washingotn on Marcy 8, 2022. Students, Post-docs, Scientists, PIs, Sponsors, Supporters and Community advocates are invited to register and attend in-person or online.
Please spread the news and help recruit your colleague to consider joining our team in making global impact on HIV and on the path to finding a cure. #recruit#pharmaceutical#scientists#jobs https://t.co/tXnSE5SQRp
University of Washington #UWSOP TLC-ART, Targeted, Long-acting, Drug-Combination Therapeutic Program is #recruiting#pharmaceutical#scientists at all levels. inquire with Matthew Hartman #TLC-ART. Available Immediately. Here is the link…https://t.co/hb4mGaGfTr
@uwnews featured a report about @UW_Pharmacy's Drug Interaction database team being awarded by the @ASCPT American Association for Clinical Pharmacology and Therapeutics. Very proud of the team led by Isabelle Ragueneau-Majlessi. Congratulation
The Medicines Patent Pool and the U Washington-TLC-ART program sign a licence agreement for enabling technology that transform short-to-long-acting injectable HIV drug combination candidate intended for worldwide access-very GLAD https://t.co/VnwMUFpLGo